Whistleblower suits arise from claims for reimbursement under Medicare, Medicaid, or TRICARE.
Anthony Calamunci, FisherBroyles, LLP
Advertisement
Articles by Anthony Calamunci, FisherBroyles, LLP
Legislation seeks to fight drug cost increases by creating transparency in the pricing activities of manufacturers and pharmacy benefit managers.
Advertisement
Latest Updated Articles
State-Level Diabetes Drug-Pricing Transparency Bills Target PBMsPublished: August 2nd 2017 | Updated:
Ohio-based Healthcare Companies Pay $19.5 Million to Settle False Medicare Claims AllegationsPublished: August 9th 2017 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Operationalizing Epcoritamab-GemOx in Practice: A Focus on EPCORE NHL-2
2
Under Pressure: A Brief Overview of the Updated Hypertension Guidelines
3
FDA Expands Adalimumab-Aaty For Pediatrics, Adolescents With Rare Inflammatory Conditions
4
Pharmacists Are Indispensable in Managing Chronic Kidney Disease
5
